PhD student’s research review reveals potential to improve colon cancer treatments
Kennedy Trust’s PhD student Alina Janney at the Kennedy Institute for Rheumatology Research has published a paper in Nature reviewing the role of the microbiome in colorectal cancer. Read more...
Oxford researchers start new trial on the use of anti-TNF to treat COVID-19 in care homes
We are hopeful that anti-TNF therapy, first identified by Professor Sir Marc Feldmann and the Trust’s President Professor Sir Ravinder Maini, might prove to be an effective treatment for patients with COVID-19. Read the full article here....
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Professors John Grainger and Tracy Hussell’s CIRCO study funded by the Kennedy Trust, which defines altered myeloid function in COVID-19 patients, has been published in Science Immunology. Read the full article here...
Coronavirus: why are some people experiencing long-term fatigue?
The Kennedy Trust and Versus Arthritis are funding an exciting new research project on fatigue led by Professor Frances Williams and Professor Carmine M. Pariante at King’s College London. Read more...
Kennedy Institute expansion
The Trust is delighted to support the development of an additional floor of the Kennedy Institute building to create much needed space for its data science and clinical trials programmes. Read more...
Sir Marc Feldmann awarded the 2020 Tang Prize in Biopharmaceutical Science
Congratulations to Sir Marc Feldmann, on receiving the 2020 Tang Prize in Biopharmaceutical Science. We are proud of our long association with Sir Marc and to have supported his joint discovery of anti-TNF therapy with Trust President, Sir Ravinder Maini....